Pine AR, Cirigliano SM, Nicholson JG, Hu Y, Linkous A, Miyaguchi K, Edwards L, Singhania R, Schwartz TH, Ramakrishna R et al..
2020.
Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary Glioblastomas.. Cancer Discov. 10(7):964-979.
Tosi U, Kommidi H, Bellat V, Marnell CS, Guo H, Adeuyan O, Schweitzer ME, Chen N, Su T, Zhang G et al..
2019.
Real-Time, in Vivo Correlation of Molecular Structure with Drug Distribution in the Brain Striatum Following Convection Enhanced Delivery.. ACS Chem Neurosci. 10(5):2287-2298.
Rajappa P, Cobb WS, Vartanian E, Huang Y, Daly L, Hoffman C, Zhang J, Shen B, Yanowitch R, Garg K et al..
2017.
Malignant Astrocytic Tumor Progression Potentiated by JAK-mediated Recruitment of Myeloid Cells.. Clin Cancer Res. 23(12):3109-3119.
Zhang S, Chiang GChia-Yi, Knapp JMarion, Zecca CM, He D, Ramakrishna R, Magge RS, Pisapia DJ, Fine HAlan, Tsiouris AJohn et al..
2020.
Grading meningiomas utilizing multiparametric MRI with inclusion of susceptibility weighted imaging and quantitative susceptibility mapping.. J Neuroradiol. 47(4):272-277.
Gerges MM, Godil SS, Rumalla K, Liechty B, Pisapia DJ, Magge RS, Schwartz TH.
2019.
Genomic profile of a primary squamous cell carcinoma arising from malignant transformation of a pineal epidermoid cyst.. Acta Neurochir (Wien). 161(9):1829-1834.
Ivanidze J, Roytman M, Lin E, Magge RS, Pisapia DJ, Liechty B, Karakatsanis N, Ramakrishna R, Knisely J, Schwartz TH et al..
2019.
Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas.. J Neuroimaging. 29(5):650-656.
Pisapia DJ, Ohara K, Bareja R, Wilkes DC, Hissong E, Croyle JA, Kim J-H, Saab J, MacDonald TY, Beg S et al..
2020.
Fusions involving BCOR and CREBBP are rare events in infiltrating glioma.. Acta Neuropathol Commun. 8(1):80.
Chidambaram S, Pannullo SC, Roytman M, Pisapia DJ, Liechty B, Magge RS, Ramakrishna R, Stieg PE, Schwartz TH, Ivanidze J.
2019.
Dynamic contrast-enhanced magnetic resonance imaging perfusion characteristics in meningiomas treated with resection and adjuvant radiosurgery.. Neurosurg Focus. 46(6):E10.
Omay SBulent, Chen Y-N, Almeida JPaulo, Ruiz-Treviño ASaul, Boockvar JA, Stieg PE, Greenfield JP, Souweidane MM, Kacker A, Pisapia DJ et al..
2018.
Do craniopharyngioma molecular signatures correlate with clinical characteristics? J Neurosurg. 128(5):1473-1478.
Chang R, Tosi U, Voronina J, Adeuyan O, Wu LY, Schweitzer ME, Pisapia DJ, Becher OJ, Souweidane MM, Maachani UB.
2019.
Combined targeting of PI3K and MEK effector pathways via CED for DIPG therapy.. Neurooncol Adv. 1(1):vdz004.
Chang R, Tosi U, Voronina J, Adeuyan O, Wu LY, Schweitzer ME, Pisapia DJ, Becher OJ, Souweidane MM, Maachani UB.
2019.
Combined targeting of PI3K and MEK effector pathways via CED for DIPG therapy.. Neurooncol Adv. 1(1):vdz004.
La Corte E, Younus I, Pivari F, Selimi A, Ottenhausen M, Forbes JA, Pisapia DJ, Dobri GA, Anand VK, Schwartz TH.
2018.
BRAF V600E mutant papillary craniopharyngiomas: a single-institutional case series.. Pituitary. 21(6):571-583.
Maachani UB, Tosi U, Pisapia DJ, Mukherjee S, Marnell CS, Voronina J, Martinez D, Santi M, Dahmane N, Zhou Z et al..
2019.
B7-H3 As a Prognostic Biomarker and Therapeutic Target in Pediatric Central Nervous System Tumors. Transl Oncol. 13(2):365-371.